Trial Profile
An Observational study to compare the efficacy of Edoxaban and Warfarin for prevention of stroke and systemic embolic events in patients with Non-Valvular Atrial Fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2018
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Embolism; Stroke
- Focus Therapeutic Use
- 25 May 2018 New trial record
- 23 May 2018 Results presented at the 23rd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research